378 related articles for article (PubMed ID: 32201951)
1. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis.
Hu Q; Zhang F; Teng W; Hao F; Zhang J; Yin M; Wang N
J Neurol; 2018 Jan; 265(1):1-11. PubMed ID: 28940083
[TBL] [Abstract][Full Text] [Related]
4. Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis.
Charokopou M; Harvey R; Srivastava K; Brandt C; Borghs S
Curr Med Res Opin; 2019 Aug; 35(8):1345-1354. PubMed ID: 30799639
[No Abstract] [Full Text] [Related]
5. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.
Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR
Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771
[TBL] [Abstract][Full Text] [Related]
6. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.
Costa J; Fareleira F; Ascenção R; Borges M; Sampaio C; Vaz-Carneiro A
Epilepsia; 2011 Jul; 52(7):1280-91. PubMed ID: 21729036
[TBL] [Abstract][Full Text] [Related]
7. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
8. Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.
Zaccara G; Giovannelli F; Bell GS; Sander JW
Eur J Clin Pharmacol; 2014 Jun; 70(6):647-54. PubMed ID: 24676410
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.
Otoul C; Arrigo C; van Rijckevorsel K; French JA
Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
11. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
Hemery C; Ryvlin P; Rheims S
Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
[TBL] [Abstract][Full Text] [Related]
12. Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.
Rheims S; Perucca E; Cucherat M; Ryvlin P
Epilepsia; 2011 Feb; 52(2):219-33. PubMed ID: 21269281
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
[TBL] [Abstract][Full Text] [Related]
14. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
15. Methods for the inclusion of real-world evidence in network meta-analysis.
Jenkins DA; Hussein H; Martina R; Dequen-O'Byrne P; Abrams KR; Bujkiewicz S
BMC Med Res Methodol; 2021 Oct; 21(1):207. PubMed ID: 34627166
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system.
Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P
J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Rosati A; Ilvento L; Lucenteforte E; Pugi A; Crescioli G; McGreevy KS; Virgili G; Mugelli A; De Masi S; Guerrini R
Epilepsia; 2018 Feb; 59(2):297-314. PubMed ID: 29270989
[TBL] [Abstract][Full Text] [Related]
19. Surgery for epilepsy.
West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
[TBL] [Abstract][Full Text] [Related]
20. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]